Walvax沃森生物

CN
EN

00

-0.22 (-0.6%)

Stock Code: 300142

Key Facts

2.4 billion

USD2.4 billion market capitalization

387 million

USD387 million revenue in 2024

78 million

USD78 million international business revenue in 2024

19.5 million

USD19.5 million of net profit attributable to Company owners in 2024

2,020 million

USD2,020 million of total asset in 2024

98%

A 98% YoY increase for international business
Financial Reports
2025.04.12
2024 Annual Report
Download
2024.10.26
2024 Third-Quarter Report
Download
2024.08.28
2024 Interim Report
Download
2024.04.25
2024 First-Quarter Report
Download
2024.04.01
2023 Annual Report
Download
2023.10.31
2023 Third-Quarter Report
Download
2023.08.28
2023 Interim Report
Download
2023.04.24
2023 First-Quarter Report
Download
2023.04.03
2022 Annual Report
Download
2022.08.11
2022 Interim Report
Download